Search Results - "Sankpal, Umesh T"

Refine Results
  1. 1

    DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B by Palii, Stela S., Van Emburgh, Beth O., Sankpal, Umesh T., Brown, Kevin D., Robertson, Keith D.

    Published in Molecular and Cellular Biology (01-01-2008)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy by Sankpal, Umesh T, Maliakal, Pius, Bose, Debashish, Kayaleh, Omar, Buchholz, Daniel, Basha, Riyaz

    Published in Current medicinal chemistry (01-08-2012)
    “…Pancreatic cancer is an aggressive malignancy with poor prognosis. Pancreatic adenocarcinoma is one of the leading causes of cancer-related deaths in the…”
    Get more information
    Journal Article
  3. 3

    Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors by Hurtado, Myrna, Sankpal, Umesh T., Kaba, Aboubacar, Mahammad, Shahela, Chhabra, Jaya, Brown, Deondra T., Gurung, Raj K., Holder, Alvin A., Vishwanatha, Jamboor K., Basha, Riyaz

    Published in Cellular physiology and biochemistry (01-01-2018)
    “…Background/Aims: Targeting survivin, an anti-apoptotic protein and mitotic regulator, is considered as an effective therapeutic option for pancreatic cancer…”
    Get full text
    Journal Article
  4. 4

    Role of KCNMA1 gene in breast cancer invasion and metastasis to brain by Khaitan, Divya, Sankpal, Umesh T, Weksler, Babette, Meister, Edward A, Romero, Ignacio A, Couraud, Pierre-Olivier, Ningaraj, Nagendra S

    Published in BMC cancer (29-07-2009)
    “…The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is…”
    Get full text
    Journal Article
  5. 5

    Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors by Basha, Riyaz, Ingersoll, Susan B, Sankpal, Umesh T, Ahmad, Sarfraz, Baker, Cheryl H, Edwards, John R, Holloway, Robert W, Kaja, Sumanth, Abdelrahim, Maen

    Published in Gynecologic oncology (01-07-2011)
    “…Abstract Objective The aberrant expression of hepatocyte growth factor and its receptor c-Met are associated with aggressive disease and poor prognosis in a…”
    Get full text
    Journal Article
  6. 6

    Environmental factors in causing human cancers: emphasis on tumorigenesis by Sankpal, Umesh T., Pius, Hima, Khan, Moeez, Shukoor, Mohammed I., Maliakal, Pius, Lee, Chris M., Abdelrahim, Maen, Connelly, Sarah F., Basha, Riyaz

    Published in Tumor biology (01-10-2012)
    “…The environment and dietary factors play an essential role in the etiology of cancer. Environmental component is implicated in ~80 % of all cancers; however,…”
    Get full text
    Journal Article
  7. 7

    Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation by Sankpal, Umesh T., Lee, Chris M., Connelly, Sarah F., Kayaleh, Omer, Eslin, Don, Sutphin, Robert, Goodison, Steven, Adwan, Lina, Zawia, Nasser H., Lichtenberger, Lenard M., Basha, Riyaz

    Published in Cellular physiology and biochemistry (01-01-2013)
    “…Background/Aims: The small molecule, Tolfenamic acid (TA) has shown anti-cancer activity in pre-clinical models and is currently in Phase I clinical trials at…”
    Get full text
    Journal Article
  8. 8

    Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model by Ningaraj, Nagendra S., Sankpal, Umesh T., Khaitan, Divya, Meister, Edward A., Vats, Tribhawan S.

    Published in Cancer biology & therapy (15-10-2009)
    “…Most anticancer drugs fail to impact patient survival since they fail to cross the blood-brain tumor barrier (BTB) at therapeutic levels. For example,…”
    Get full text
    Journal Article
  9. 9

    Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro by Robertson, Andrea K., Geiman, Theresa M., Sankpal, Umesh T., Hager, Gordon L., Robertson, Keith D.

    “…DNA methylation is an epigenetic modification of the genome critical for numerous processes, including transcriptional repression and maintenance of chromatin…”
    Get full text
    Journal Article
  10. 10

    Impact of the Microbiome on the Immune System by Lambring, Christoffer B, Siraj, Sohail, Patel, Krishna, Sankpal, Umesh T, Mathew, Stephen, Basha, Riyaz

    Published in Critical reviews in immunology (2019)
    “…Higher organisms are all born with general immunity as well as with, increasingly, more specific immune systems. All immune mechanisms function with the intent…”
    Get full text
    Journal Article
  11. 11

    Relevance of drug metabolizing enzyme activity modulation by tea polyphenols in the inhibition of esophageal tumorigenesis by Maliakal, Pius, Sankpal, Umesh T, Basha, Riyaz, Maliakal, Cima, Ledford, Andrea, Wanwimolruk, Sompon

    “…Tea is a popular, socially accepted, drink that is enjoyed by millions of people. A growing body of evidence suggests that moderate consumption of tea may…”
    Get more information
    Journal Article
  12. 12

    Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells by Patil, Shruti, Sankpal, Umesh T., Hurtado, Myrna, Bowman, W. Paul, Murray, Jeffrey, Borgmann, Kathleen, Ghorpade, Anuja, Sutphin, Robert, Eslin, Don, Basha, Riyaz

    Published in Gene (15-07-2019)
    “…Medulloblastoma (MB) is characterized by highly invasive embryonal neuro-epithelial tumors that metastasize via cerebrospinal fluid. MB is difficult to treat…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth by Shelake, Sagar, Sankpal, Umesh T., Paul Bowman, W., Wise, Matthew, Ray, Anish, Basha, Riyaz

    Published in Investigational new drugs (01-04-2017)
    “…Summary Transcription factor Specificity protein 1 (Sp1) and its downstream target survivin (inhibitor of apoptosis protein), play major roles in the…”
    Get full text
    Journal Article
  15. 15

    Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer by Hurtado, Myrna, Sankpal, Umesh T., Ranjan, Amalendu, Maram, Rajasekhar, Vishwanatha, Jamboor K., Nagaraju, Ganji Purnachandra, El-Rayes, Bassel F., Basha, Riyaz

    Published in Critical reviews in oncology/hematology (01-06-2018)
    “…•Benefits of investigating the strategies to induce the efficacy of chemotherapy and or radiation.•Summary of investigational agents tested for inducing…”
    Get full text
    Journal Article
  16. 16

    Copper-tolfenamic acid: evaluation of stability and anti-cancer activity by Hurtado, Myrna, Sankpal, Umesh T., Chhabra, Jaya, Brown, Deondra T., Maram, Rajasekhar, Patel, Rafid, Gurung, Raj K., Simecka, Jerry, Holder, Alvin A., Basha, Riyaz

    Published in Investigational new drugs (01-02-2019)
    “…Summary The non-steroidal anti-inflammatory drug, Tolfenamic acid (TA) acts as an anti-cancer agent in several adult and pediatric cancer models. Copper (Cu)…”
    Get full text
    Journal Article
  17. 17

    Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells by Sankpal, Umesh T, Goodison, Steve, Jones-Pauley, Michelle, Hurtado, Myrna, Zhang, Fan, Basha, Riyaz

    Published in Oncotarget (28-02-2017)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) are being tested extensively for their role in the treatment and prevention of several cancers. Typically NSAIDs…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma by Sridhar, Swathi, Sharma, Ishna, Sankpal, Umesh T, Ghabach, Bassam, Narra, Kalyani, Neerukonda, Latha, Basha, Riyaz

    Published in Critical reviews in oncogenesis (2020)
    “…Liver cancer is the 6th leading cause of cancer related deaths in the US even though it ranks 14th in incidence. More men are diagnosed with liver cancer than…”
    Get more information
    Journal Article